PAPER Morishima-Kawashima M, Oshima N, Ogata H, Yamaguchi H, Yoshimura M, Sugihara S, Ihara Y

Effect of apolipoprotein E allele epsilon4 on the initial phase of amyloid beta-protein accumulation in the human brain.

Am J Pathol. 2000 Dec;157(6):2093-9. PubMed.

PAPER Schmidt AM, Yan SD, Yan SF, Stern DM

The biology of the receptor for advanced glycation end products and its ligands.

Biochim Biophys Acta. 2000 Dec 20;1498(2-3):99-111. PubMed.

PAPER Ihara Y

[The current status and perspectives in Alzheimer's disease research].

Nihon Ronen Igakkai Zasshi. 2000 Sep;37(9):680-6. PubMed.

PAPER Chiou GC, Xuan B, Liu Q, Yamasaki T, Okawara T

Inhibition of interleukin-1-induced uveitis and corneal fibroblast proliferation by interleukin-1 blockers.

J Ocul Pharmacol Ther. 2000 Oct;16(5):407-18. PubMed.

PAPER Bigler ED, Lowry CM, Anderson CV, Johnson SC, Terry J, Steed M

Dementia, quantitative neuroimaging, and apolipoprotein E genotype.

AJNR Am J Neuroradiol. 2000 Nov-Dec;21(10):1857-68. PubMed.

PAPER Rombouts SA, Barkhof F, Veltman DJ, Machielsen WC, Witter MP, Bierlaagh MA, Lazeron RH, Valk J, Scheltens P

Functional MR imaging in Alzheimer's disease during memory encoding.

AJNR Am J Neuroradiol. 2000 Nov-Dec;21(10):1869-75. PubMed.

PAPER Jackson T

Drugs for Alzheimer's disease

BMJ. 2000 Dec 9;321(7274):1478B. PubMed.

PAPER Wilcock GK, Lilienfeld S, Gaens E

Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group.

BMJ. 2000 Dec 9;321(7274):1445-9. PubMed.

PAPER Gorman AM, Ceccatelli S, Orrenius S

Role of mitochondria in neuronal apoptosis.

Dev Neurosci. 2000 Sep-Dec;22(5-6):348-58. PubMed.

PAPER Scherder EJ, Bouma A

Visual analogue scales for pain assessment in Alzheimer's disease.

Gerontology. 2000 Jan-Feb;46(1):47-53. PubMed.

PAPER Berthault D

[Myosotis, and do not forget the Alzheimer patients].

Soins Gerontol. 2000 May-Jun;(23):33-5. PubMed.

PAPER Haas HL, Selbach O

Functions of neuronal adenosine receptors.

Naunyn Schmiedebergs Arch Pharmacol. 2000 Nov;362(4-5):375-81. PubMed.

PAPER Thompson PM, Mega MS, Woods RP, Zoumalan CI, Lindshield CJ, Blanton RE, Moussai J, Holmes CJ, Cummings JL, Toga AW

Cortical change in Alzheimer's disease detected with a disease-specific population-based brain atlas.

Cereb Cortex. 2001 Jan;11(1):1-16. PubMed.

PAPER Csernansky JG, Wang L, Joshi S, Miller JP, Gado M, Kido D, McKeel D, Morris JC, Miller MI

Early DAT is distinguished from aging by high-dimensional mapping of the hippocampus. Dementia of the Alzheimer type.

Neurology. 2000 Dec 12;55(11):1636-43. PubMed.

PAPER Wang JC, Kwon JM, Shah P, Morris JC, Goate A

Effect of APOE genotype and promoter polymorphism on risk of Alzheimer's disease.

Neurology. 2000 Dec 12;55(11):1644-9. PubMed.